114 results
424B3
IMUX
Immunic Inc
30 Apr 24
Prospectus supplement
5:16pm
return in the short term or long term. Investing in our common stock is speculative and involves a high degree of risk and should be undertaken only
8-K
EX-99.1
IMUX
Immunic Inc
22 Feb 24
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
6:35am
expenses and other current assets
Total current assets
Property and equipment, net
Right of use asset, net
Other long-term assets
Total assets …
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses
Other current liabilities
Total current liabilities
Long-term liabilities
PRE 14A
wys4r1uud9
24 Jan 24
Preliminary proxy
5:05pm
8-K
EX-10.2
ehnj0y
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.4
fo23w
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.3
qicupa6tc2m d643k
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.1
978 ssxktmcmqudh
21 Dec 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-99.1
bqiro8
14 Nov 23
Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:38am
8-K
EX-99.1
xprm4dsr8t33zg 1n87
3 Aug 23
Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:44am
8-K
EX-99.1
sm78ug
11 May 23
Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:51am
8-K
EX-99.1
xes1s gtj
4 May 23
Other Events
6:49am